Triple Negative Breast Cancer Study Tests Way of Monitoring Metastasis Using …

Triple Negative Breast Cancer Study Tests Way of Monitoring Metastasis Using …

The trial, “A Pilot Surveillance Study to Monitor Natural Killer Cells and Circulating Tumor Cells in Previously Treated Non-metastatic Triple Negative Breast Cancer,” will use the company's ClearID genomic test, powered by the LiquidBiopsy technology, …

(Visited 4 times, 1 visits today)
4
Like
Save

Comments

Comments are disabled for this post.